EXEL
EXEL
NASDAQ · Biotechnology

Exelixis Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$41.57
+0.16 (+0.39%)
As of Mar 24, 9:43 PM ET ·
Analyst Consensus
Buy
27
Analysts
High
Coverage
Buy 15 56%
Hold 11 41%
Sell 1 4%
Price Target
Analyst Price Target +179.3% upside
Low Target $78.53
Average Target $116.10
High Target $123.77
Current Price $41.57
Current
$41.57
Target
$116.10
$78.53 $116.10 avg $123.77
Scenario Analysis
Bear Case
$78.53
88.9%
Low target
Base Case
$116.10
+179.3%
Avg target
Bull Case
$123.77
+197.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$49.62
-16.2% from high
52-Week Low
$32.38
+28.4% from low
50-Day SMA
$43.59
-4.6% vs SMA
200-Day SMA
$41.49
+0.2% vs SMA
RSI (14)
62.0
Neutral
Target vs 52W High
$116.10
+134.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%